View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Erlotinib 150 / Bevacizumab 15, Non-Small Cell (Adeno) Lung Carcinoma
Protocol-ID: 742 V1.0 (Mini), ERLO150/BEVA15, NSCLC (Adeno)Indication(s)
- Lung Carcinoma, Non-Small Cell; ICD-10 C34.-
EGFR activating mutation & non-squamous
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 29.07.2016